(R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT7Receptor Antagonist
- 1 February 1998
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (5), 655-657
- https://doi.org/10.1021/jm970519e
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Four 5‐Hydroxytryptamine7 (5‐HT7) Receptor Isoforms in Human and Rat Produced by Alternative Splicing: Species Differences Due to Altered Intron‐Exon OrganizationJournal of Neurochemistry, 1997
- Contribution of adrenal hormones to nicotine‐induced inhibition of synovial plasma extravasation in the ratBritish Journal of Pharmacology, 1997
- Characterization of putative 5-ht7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular veinBritish Journal of Pharmacology, 1996
- Functional, endogenously expressed 5‐hydroxytryptamine 5‐ht7 receptors in human vascular smooth muscle cellsBritish Journal of Pharmacology, 1996
- A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5‐ht7 receptor in rat brainBritish Journal of Pharmacology, 1996
- Regulation of histamine‐ and UTP‐induced increases in Ins(1,4,5)P3, Ins (1,3,4,5)P4 and Ca2+ by cyclic AMP in DDT1 MF‐2 cellsBritish Journal of Pharmacology, 1995
- Cloning and Expression of a 5‐Hydroxytryptamine7 Receptor Positively Coupled to Adenylyl CyclaseJournal of Neurochemistry, 1994
- Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.Proceedings of the National Academy of Sciences, 1993
- A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythmsNeuron, 1993